EIF2A and acute lymphoblastic leukemia: However, we have also reported that treatment of ALL cells with the proteasome DUB inhibitor VLX1570 did not induce detectable phosphorylation of eIF2α, whereas protein synthesis was nevertheless inhibited [33].